bremelanotide
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Bremelanotide is an injectable indicated for premenopausal women with hypoactive sexual desire disorder (HSDD).
INTRODUCTION:Bremelanotide, an investigational new drug, is a melanocortin 4 receptor agonist that has demonstrated efficacy in…
Metadoxine (pyridoxol L-2-pyrrolidone-5-carboxylate) is an ion-pair salt of pyridoxine (vitamin B6) and 2-pyrrolidone…
INTRODUCTION: Bremelanotide is a novel heptapeptide melanocortin receptor-4 agonist. This study examined its at-home, as-needed…
INTRODUCTION: Bremelanotide is a novel heptapeptide melanocortin receptor-4 agonist. This study examined its subcutaneous self…
For recent a decade, field of female sexual dysfunction for classification, it’s pathophysiology and treatment has been focused…
The sexual consequences of breast cancer and its treatments are well known. Sexual difficulties include alteration in hormonal…
An article in the Journal of Sexual Medicine recently reported the results of a Phase IIa clinical trial on the use of…